Molecular biology experiments, including MTT, LDH, EDU, and clonal formation assays, have provided further evidence that the knockdown of DDX60 can effectively inhibit the proliferation of pancreatic cancer cells. The gene discussed is DDX60; the disease is familial pancreatic carcinoma.